{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:07:02Z","timestamp":1772798822581,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1186\/s13054-020-03014-1","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T13:07:20Z","timestamp":1591103240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?"],"prefix":"10.1186","volume":"24","author":[{"given":"Martin","family":"Cour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Ovize","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4565-2454","authenticated-orcid":false,"given":"Laurent","family":"Argaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"key":"3014_CR1","doi-asserted-by":"publisher","unstructured":"Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. Epub 2020 Apr 13. https:\/\/doi.org\/10.1001\/jama.2020.6019.","DOI":"10.1001\/jama.2020.6019"},{"key":"3014_CR2","doi-asserted-by":"publisher","unstructured":"Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, Shrestha BR, Arabi YM, Ng J, Gomersall CD, Nishimura M, Koh Y, Du B, Asian Critical Care Clinical Trials Group. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. Epub 2020 Apr 6. https:\/\/doi.org\/10.1016\/S2213-2600(20)30161-2.","DOI":"10.1016\/S2213-2600(20)30161-2"},{"issue":"5","key":"3014_CR3","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1476-5381.2011.01700.x","volume":"165","author":"DJ Hausenloy","year":"2012","unstructured":"Hausenloy DJ, Boston-Griffiths EA, Yellon DM. Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent. Br J Pharmacol. 2012;165(5):1235\u201345. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01700.x.","journal-title":"Br J Pharmacol"},{"key":"3014_CR4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bcp.2019.03.022","volume":"163","author":"AM Liddicoat","year":"2019","unstructured":"Liddicoat AM, Lavelle EC. Modulation of innate immunity by cyclosporine A. Biochem Pharmacol. 2019;163:472\u201380. https:\/\/doi.org\/10.1016\/j.bcp.2019.03.022.","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"3014_CR5","doi-asserted-by":"publisher","first-page":"e1002331","DOI":"10.1371\/journal.ppat.1002331","volume":"7","author":"S Pfefferle","year":"2011","unstructured":"Pfefferle S, Schopf J, Kogl M, Friedel CC, Muller MA, Carbajo-Lozoya J, Stellberger T, von Dall\u2019Armi E, Herzog P, Kallies S, Niemeyer D, Ditt V, Kuri T, Zust R, Pumpor K, Hilgenfeld R, Schwarz F, Zimmer R, Steffen I, Weber F, Thiel V, Herrler G, Thiel HJ, Schwegmann-Wessels C, Pohlmann S, Haas J, Drosten C, von Brunn A. The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog. 2011;7(10):e1002331. https:\/\/doi.org\/10.1371\/journal.ppat.1002331.","journal-title":"PLoS Pathog"},{"key":"3014_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.virol.2018.06.011","volume":"522","author":"AH de Wilde","year":"2018","unstructured":"de Wilde AH, Pham U, Posthuma CC, Snijder EJ. Cyclophilins and cyclophilin inhibitors in nidovirus replication. Virology. 2018;522:46\u201355. https:\/\/doi.org\/10.1016\/j.virol.2018.06.011.","journal-title":"Virology."},{"issue":"12","key":"3014_CR7","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1016\/j.bbadis.2015.09.004","volume":"1852","author":"F Fonai","year":"2015","unstructured":"Fonai F, Priber JK, Jakus PB, Kalman N, Antus C, Pollak E, Karsai G, Tretter L, Sumegi B, Veres B. Lack of cyclophilin D protects against the development of acute lung injury in endotoxemia. Biochim Biophys Acta. 2015;1852(12):2563\u201373. https:\/\/doi.org\/10.1016\/j.bbadis.2015.09.004.","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"3014_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000458760","volume":"100","author":"J Li","year":"2017","unstructured":"Li J, Yan Z, Fang Q. A mechanism study underlying the protective effects of cyclosporine-A on lung ischemia-reperfusion injury. Pharmacology. 2017;100(1\u20132):83\u201390. https:\/\/doi.org\/10.1159\/000458760.","journal-title":"Pharmacology."},{"issue":"5","key":"3014_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamacardio.2016.1701","volume":"1","author":"L Argaud","year":"2016","unstructured":"Argaud L, Cour M, Dubien PY, Giraud F, Jossan C, Riche B, Hernu R, Darmon M, Poncelin Y, Tch\u00e9nio X, Quenot JP, Freysz M, Kamga C, Beuret P, Usseglio P, Badet M, Anette B, Chaulier K, Alasan E, Sadoune S, Bobbia X, Z\u00e9ni F, Gueugniaud PY, Robert D, Roy P, Ovize M, CYRUS Study Group. Effect of cyclosporine in nonshockable out-of-hospital cardiac arrest: the CYRUS Randomized Clinical Trial. JAMA Cardiol. 2016;1(5):557\u201365. https:\/\/doi.org\/10.1001\/jamacardio.2016.1701.","journal-title":"JAMA Cardiol"},{"key":"3014_CR10","doi-asserted-by":"publisher","unstructured":"Kreitmann L, Ovize M, Argaud L, Cour M, for the CYRUS Study Group. Cyclosporine A prevents cardiac arrest-induced acute respiratory failure: a post-hoc analysis of the CYRUS trial. Intensive Care Med Epub 2020 Apr 21. https:\/\/doi.org\/10.1007\/s00134-020-06043-0.","DOI":"10.1007\/s00134-020-06043-0"},{"key":"3014_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.resuscitation.2019.02.048","volume":"138","author":"M Cour","year":"2019","unstructured":"Cour M, Jahandiez V, Bochaton T, Venet F, Ovize M, Monneret G, Argaud L. Cyclosporine A prevents ischemia-reperfusion-induced lymphopenia after out-of-hospital cardiac arrest: a predefined sub-study of the CYRUS trial. Resuscitation. 2019;138:129\u201331. https:\/\/doi.org\/10.1016\/j.resuscitation.2019.02.048.","journal-title":"Resuscitation."},{"issue":"11","key":"3014_CR12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","volume":"373","author":"TT Cung","year":"2015","unstructured":"Cung TT, Morel O, Cayla G, Rioufol G, Garcia-Dorado D, Angoulvant D, Bonnefoy-Cudraz E, Gu\u00e9rin P, Elbaz M, Delarche N, Coste P, Vanzetto G, Metge M, Aupetit JF, Jouve B, Motreff P, Tron C, Labeque JN, Steg PG, Cottin Y, Range G, Clerc J, Claeys MJ, Coussement P, Prunier F, Moulin F, Roth O, Belle L, Dubois P, Barragan P, Gilard M, Piot C, Colin P, De Poli F, Morice MC, Ider O, Dubois-Rand\u00e9 JL, Unterseeh T, Le Breton H, B\u00e9ard T, Blanchard D, Grollier G, Malquarti V, Staat P, Sudre A, Elmer E, Hansson MJ, Bergerot C, Boussaha I, Jossan C, Derumeaux G, Mewton N, Ovize M. Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med. 2015;373(11):1021\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1505489.","journal-title":"N Engl J Med"},{"issue":"2","key":"3014_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/ALN.0000000000000331","volume":"121","author":"P Chiari","year":"2014","unstructured":"Chiari P, Angoulvant D, Mewton N, Desebbe O, Obadia JF, Robin J, Farhat F, Jegaden O, Bastien O, Lehot JJ, Ovize M. Cyclosporine protects the heart during aortic valve surgery. Anesthesiology. 2014;121(2):232\u20138. https:\/\/doi.org\/10.1097\/ALN.0000000000000331.","journal-title":"Anesthesiology."},{"issue":"2","key":"3014_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1056\/NEJMoa043204","volume":"354","author":"AT Iacono","year":"2006","unstructured":"Iacono AT, Johnson BA, Grgurich WF, Youssef JG, Corcoran TE, Seiler DA, Dauber JH, Smaldone GC, Zeevi A, Yousem SA, Fung JJ, Burckart GJ, McCurry KR, Griffith BP. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med. 2006;354(2):141\u201350. https:\/\/doi.org\/10.1056\/NEJMoa043204.","journal-title":"N Engl J Med"},{"issue":"4","key":"3014_CR15","doi-asserted-by":"publisher","first-page":"00167","DOI":"10.1183\/23120541.00167-2019","volume":"5","author":"A Iacono","year":"2019","unstructured":"Iacono A, Wijesinha M, Rajagopal K, Murdock N, Timofte I, Griffith B, Terrin M. A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation. ERJ Open Res. 2019;5(4):00167\u20132019. https:\/\/doi.org\/10.1183\/23120541.00167-2019.","journal-title":"ERJ Open Res"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03014-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-020-03014-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03014-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:17:50Z","timestamp":1622593070000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-020-03014-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3014"],"URL":"https:\/\/doi.org\/10.1186\/s13054-020-03014-1","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"assertion":[{"value":"14 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no financial or other conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"276"}}